{"id":70072,"date":"2026-05-01T06:08:34","date_gmt":"2026-05-01T06:08:34","guid":{"rendered":"https:\/\/medsbase.com\/diabetes-starter-pack\/"},"modified":"2026-05-01T10:49:10","modified_gmt":"2026-05-01T10:49:10","slug":"diabetes-starter-pack","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/diabetes-starter-pack\/","title":{"rendered":"Startovac\u00ed bal\u00ed\u010dek pro diabetes \u2014 Glycomet SR 1000 + Glycomet-GP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fffbea;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 22px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 10px 0;font-size:20px;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Diabetes Starter Pack?<\/h3>\n<p style=\"margin:0;\">Diabetes Starter Pack od MedsBase kombinuje <strong>metformin s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm 1000 mg<\/strong> (Glycomet SR od USV) s <strong>kombinac\u00ed metforminu a glimepiridu 500 mg + 2 mg<\/strong> (Glycomet-GP) \u2014 dva nej\u010dast\u011bji p\u0159edepisovan\u00e9 l\u00e9ky prvn\u00ed volby a druh\u00e9 linie pro nov\u011b diagnostikovan\u00fd diabetes 2. typu podle doporu\u010den\u00ed ADA, EASD a NICE z roku 2024. Metformin SR poskytuje z\u00e1kladn\u00ed hypoglykemick\u00fd \u00fa\u010dinek; kombinace metformin-glimepirid p\u0159id\u00e1v\u00e1 sekretagogickou aktivitu inzul\u00ednu pro pacienty, kte\u0159\u00ed pot\u0159ebuj\u00ed siln\u011bj\u0161\u00ed l\u00e9k druh\u00e9 linie. Mo\u017enosti dod\u00e1n\u00ed: 1, 3 nebo 6 m\u011bs\u00edc\u016f. Pouze pod dohledem specialisty.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co obsahuje startovac\u00ed bal\u00ed\u010dek pro diabetes<\/h2>\n<ul>\n<li><strong><a href=\"https:\/\/medsbase.com\/cs\/glycomet-sr\/\">Glycomet SR 1000 mg<\/a><\/strong> (metformin hydrochlorid s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm, USV India). Prvn\u00ed volba peror\u00e1ln\u00ed l\u00e9\u010dby diabetu 2. typu podle v\u0161ech hlavn\u00edch sm\u011brnic od roku 1998. Mechanismus: aktivace AMPK v j\u00e1trech potla\u010duje jatern\u00ed glukoneogenezi (hlavn\u00ed zdroj fasting hyperglyk\u00e9mie u T2DM), s vedlej\u0161\u00edmi \u00fa\u010dinky na GLP-1, st\u0159evn\u00ed mikrobiom a perifern\u00ed inzulinovou senzitivitu. Forma SR sni\u017euje GI ne\u017e\u00e1douc\u00ed \u00fa\u010dinky oproti okam\u017eit\u011b uvol\u0148ovan\u00e9mu metforminu.<\/li>\n<li><strong><a href=\"https:\/\/medsbase.com\/cs\/glycomet-gp\/\">Glycomet-GP 500 mg + 2 mg<\/a><\/strong> (metformin + glimepirid). P\u0159id\u00e1v\u00e1 sulfonylureu \u2013 glimepirid se v\u00e1\u017ee na podjednotku SUR1 pankreatick\u00fdch K-ATP kan\u00e1l\u016f a spou\u0161t\u00ed sekreci inzulinu. Pou\u017e\u00edv\u00e1 se jako druh\u00e1 volba, kdy\u017e HbA1c z\u016fst\u00e1v\u00e1 nad c\u00edlovou hodnotou p\u0159i samotn\u00e9m metforminu, zejm\u00e9na kdy\u017e jsou SGLT-2 inhibitory nebo GLP-1 agonist\u00e9 nedostupn\u00e9 nebo finan\u010dn\u011b nedostupn\u00e9.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Pro\u010d kombinovat tyto dva produkty?<\/h2>\n<p>U nov\u011b diagnostikovan\u00e9ho diabetu 2. typu je standardn\u00ed postup ADA\/EASD: nejprve metformin, zv\u00fd\u0161it d\u00e1vku na 2000 mg\/den b\u011bhem 4\u20138 t\u00fddn\u016f, zkontrolovat HbA1c po 12 t\u00fddnech. Pokud HbA1c z\u016fst\u00e1v\u00e1 nad c\u00edlem (obvykle &gt; 7 %) a neexistuj\u00ed specifick\u00e9 indikace pro SGLT-2\/GLP-1 (\u017e\u00e1dn\u00e1 ASCVD, CKD nebo HF), sulfonylurea jako glimepirid je nej\u010dast\u011bji pou\u017e\u00edvanou dostupnou druhou volbou v mnoha \u010d\u00e1stech sv\u011bta.<\/p>\n<p>Tento bal\u00ed\u010dek pokr\u00fdv\u00e1 jak z\u00e1kladn\u00ed re\u017eim, tak re\u017eim s nav\u00fd\u0161en\u00edm d\u00e1vky v jedn\u00e9 z\u00e1silce. Pacienti, kte\u0159\u00ed dob\u0159e sn\u00e1\u0161ej\u00ed metformin v d\u00e1vce 2000 mg\/den, mohou pokra\u010dovat pouze s Glycomet SR (vyu\u017eijte 6m\u011bs\u00ed\u010dn\u00ed balen\u00ed jako udr\u017eovac\u00ed l\u00e9\u010dbu). Pacienti, jejich\u017e HbA1c z\u016fst\u00e1v\u00e1 zv\u00fd\u0161en\u00e9, mohou p\u0159idat Glycomet-GP \u2013 typicky nahradit jednu z d\u00e1vek metforminu SR kombinac\u00ed, aby celkov\u00e1 d\u00e1vka metforminu z\u016fstala p\u0159ibli\u017en\u011b stejn\u00e1.<\/p>\n<h2 class=\"wp-block-heading\">Pro koho je tento bal\u00ed\u010dek ur\u010den<\/h2>\n<p><strong>Nejvhodn\u011bj\u0161\u00ed kandid\u00e1ti:<\/strong><\/p>\n<ul>\n<li>Dosp\u011bl\u00ed nov\u011b diagnostikovan\u00ed s diabetem 2. typu (HbA1c 6,5\u20139,0 %) za\u010d\u00ednaj\u00edc\u00ed prvn\u00ed lini\u00ed peror\u00e1ln\u00ed l\u00e9\u010dby<\/li>\n<li>Pacienti na monoterapii metforminem, jejich\u017e HbA1c nedos\u00e1hlo c\u00edle po 12+ t\u00fddnech p\u0159i maxim\u00e1ln\u00ed tolerovan\u00e9 d\u00e1vce<\/li>\n<li>Pacienti v regionech, kde jsou SGLT-2 inhibitory nebo GLP-1 receptorov\u00e9 agonist\u00e9 nedostupn\u00e9 nebo finan\u010dn\u011b nedostupn\u00e9, kde sulfonylurey z\u016fst\u00e1vaj\u00ed praktickou druhou volbou<\/li>\n<li>Pacienti bez ASCVD, HF nebo CKD, kde kardio-ren\u00e1ln\u00ed v\u00fdhody SGLT-2\/GLP-1 nejsou specificky aplikovateln\u00e9<\/li>\n<\/ul>\n<p><strong>NEN\u00cd vhodn\u00e9 pro:<\/strong><\/p>\n<ul>\n<li>Diabetes 1. typu \u2013 vy\u017eaduje inzulinovou substituci, ne inzulinov\u00e9 sekretagogy<\/li>\n<li>HbA1c &gt; 10 % s hyperglykemick\u00fdmi p\u0159\u00edznaky \u2013 za\u010d\u00edt s inzulinem, ne pouze s peror\u00e1ln\u00edmi l\u00e9ky<\/li>\n<li>eGFR &lt; 30 ml\/min \u2013 metformin je kontraindikov\u00e1n pod touto hranic\u00ed (riziko lakt\u00e1tov\u00e9 acid\u00f3zy)<\/li>\n<li>Akutn\u00ed onemocn\u011bn\u00ed, dehydratace, kontrastn\u00ed vy\u0161et\u0159en\u00ed do 48 hodin \u2014 do\u010dasn\u011b vysadit metformin<\/li>\n<li>T\u011b\u017ek\u00e1 jatern\u00ed porucha (Child-Pugh B nebo C)<\/li>\n<li>T\u011bhotenstv\u00ed \u2014 p\u0159ej\u00edt na inzulin pod odborn\u00fdm dohledem; metformin lze v n\u011bkter\u00fdch p\u0159\u00edpadech pokra\u010dovat pouze u t\u011bhotensk\u00fdch protokol\u016f souvisej\u00edc\u00edch s PCOS<\/li>\n<li>Nadm\u011brn\u00fd p\u0159\u00edjem alkoholu \u2014 zvy\u0161uje riziko lakt\u00e1tov\u00e9 acid\u00f3zy p\u0159i u\u017e\u00edv\u00e1n\u00ed metforminu<\/li>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na sulfonylmo\u010doviny (zk\u0159\u00ed\u017een\u00e1 reaktivita se sulfonamidov\u00fdmi antibiotiky)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Jak spr\u00e1vn\u011b pou\u017e\u00edvat balen\u00ed<\/h2>\n<p><strong>Glycomet SR 1000 mg (metformin SR)<\/strong><\/p>\n<ul>\n<li><strong>T\u00fdden 1\u20132:<\/strong> 500 mg (p\u016fl tablety, pokud mo\u017eno s d\u011bl\u00edc\u00ed r\u00fdhou \u2014 nebo pou\u017e\u00edt variantu 500 mg) jednou denn\u011b s nejv\u011bt\u0161\u00edm j\u00eddlem dne.<\/li>\n<li><strong>T\u00fdden 3\u20134:<\/strong> 500 mg dvakr\u00e1t denn\u011b (nebo 1000 mg jednou denn\u011b s ve\u010de\u0159\u00ed).<\/li>\n<li><strong>T\u00fdden 5+:<\/strong> 1000 mg dvakr\u00e1t denn\u011b (c\u00edlov\u00e1 d\u00e1vka; n\u011bkte\u0159\u00ed pacienti toleruj\u00ed 2500 mg\/den).<\/li>\n<li>V\u017edy u\u017e\u00edvejte s j\u00eddlem. Formulace SR se preferuje jednou denn\u011b (s ve\u010de\u0159\u00ed); dvakr\u00e1t denn\u011b je p\u0159ijateln\u00e9.<\/li>\n<li>Nedr\u0165te a ne\u017ev\u00fdkejte tabletu SR \u2014 naru\u0161uje to matrix s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm.<\/li>\n<\/ul>\n<p><strong>Glycomet-GP 500 mg + 2 mg (p\u0159i zvy\u0161ov\u00e1n\u00ed d\u00e1vky)<\/strong><\/p>\n<ul>\n<li><strong>Po\u010d\u00e1te\u010dn\u00ed d\u00e1vka:<\/strong> 1 tableta s sn\u00eddan\u00ed. Nahrazuje jednu z rann\u00edch d\u00e1vek metforminu SR, aby celkov\u00e1 d\u00e1vka metforminu z\u016fstala kolem 2000 mg\/den.<\/li>\n<li><strong>Titrace:<\/strong> pokud je HbA1c po 8\u201312 t\u00fddnech st\u00e1le nad c\u00edlovou hodnotou, zvy\u0161te na 1 tabletu s sn\u00eddan\u00ed a 1 tabletu s ve\u010de\u0159\u00ed \u2014 ale kontrolujte hladinu gluk\u00f3zy nala\u010dno a sledujte p\u0159\u00edznaky hypoglyk\u00e9mie.<\/li>\n<li>U\u017e\u00edvejte s j\u00eddlem, abyste sn\u00ed\u017eili riziko hypoglyk\u00e9mie.<\/li>\n<li>M\u011bjte u sebe gluk\u00f3zov\u00e9 tablety nebo slazenou \u0161\u0165\u00e1vu, pokud \u0159\u00edd\u00edte, dr\u017e\u00edte p\u016fst nebo prov\u00e1d\u00edte dlouhodob\u00e9 cvi\u010den\u00ed \u2014 sulfonylmo\u010doviny zp\u016fsobuj\u00ed hypoglyk\u00e9mii, samotn\u00fd metformin ne.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Bezpe\u010dnost kombinovan\u00e9ho u\u017e\u00edv\u00e1n\u00ed<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:14px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>Varov\u00e1n\u00ed p\u0159ed hypoglyk\u00e9mi\u00ed<\/strong><\/p>\n<p style=\"margin:0;\">Glimepirid zp\u016fsobuje hypoglyk\u00e9mii; metformin ne (p\u0159i samostatn\u00e9m u\u017e\u00edv\u00e1n\u00ed). Jakmile p\u0159id\u00e1te Glycomet-GP, m\u00e1te poprv\u00e9 skute\u010dn\u00e9 riziko hypoglyk\u00e9mie. P\u0159\u00edznaky: pocen\u00ed, t\u0159es, hlad, bu\u0161en\u00ed srdce, rozmazan\u00e9 vid\u011bn\u00ed, zmatenost. <strong>V\u017edy m\u011bjte u sebe rychle p\u016fsob\u00edc\u00ed sacharidy<\/strong> (gluk\u00f3zov\u00e9 tablety, \u0161\u0165\u00e1vu, cukr). Star\u0161\u00ed pacienti a pacienti s poruchou funkce ledvin jsou vystaveni vy\u0161\u0161\u00edmu riziku a mohou pot\u0159ebovat ni\u017e\u0161\u00ed d\u00e1vkov\u00e1n\u00ed glimepiridu.<\/p>\n<\/div>\n<p>Kombinace metforminu a glimepiridu je dob\u0159e prostudov\u00e1na \u2014 nevykazuje klinicky v\u00fdznamnou farmakokinetickou interakci. Tato kombinace je standardn\u00edm postupem p\u0159i eskalaci l\u00e9\u010dby ji\u017e v\u00edce ne\u017e 25 let.<\/p>\n<p>Dbejte na: deficit vitaminu B12 p\u0159i dlouhodob\u00e9m u\u017e\u00edv\u00e1n\u00ed metforminu (ro\u010dn\u00ed kontrola B12 po 4+ letech); do\u010dasn\u00e9 vysazen\u00ed p\u0159ed kontrastn\u00edm vy\u0161et\u0159en\u00edm (48 hodin p\u0159ed a po pod\u00e1n\u00ed IV kontrastu); omezen\u00ed alkoholu na 1\u20132 n\u00e1poje p\u0159i jedn\u00e9 p\u0159\u00edle\u017eitosti; zm\u011bny hmotnosti (sulfonylmo\u010doviny m\u00edrn\u011b zvy\u0161uj\u00ed hmotnost, metformin je neutr\u00e1ln\u00ed); revize medikace p\u0159i ka\u017ed\u00e9m nov\u00e9m p\u0159edpisu (mnoho l\u00e9k\u016f interaguje se sulfonylmo\u010dovinami).<\/p>\n<h2 class=\"wp-block-heading\">Pl\u00e1n monitorov\u00e1n\u00ed<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Test<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Frekvence<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">HbA1c<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ka\u017ed\u00e9 3 m\u011bs\u00edce do dosa\u017een\u00ed c\u00edlov\u00fdch hodnot, pot\u00e9 ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Gluk\u00f3za nala\u010dno (dom\u00e1c\u00ed glukometr)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Denn\u011b prvn\u00ed 4 t\u00fddny, pot\u00e9 1\u20133\u00d7 t\u00fddn\u011b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ren\u00e1ln\u00ed funkce (kreatinin, eGFR)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vstupn\u00ed vy\u0161et\u0159en\u00ed; ka\u017ed\u00fdch 6\u201312 m\u011bs\u00edc\u016f<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Vitamin B12<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Po 4 letech u\u017e\u00edv\u00e1n\u00ed metforminu; n\u00e1sledn\u011b ka\u017edoro\u010dn\u011b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Jatern\u00ed testy<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vstupn\u00ed vy\u0161et\u0159en\u00ed; ka\u017edoro\u010dn\u011b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Lipidov\u00fd panel + TK<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Vstupn\u00ed vy\u0161et\u0159en\u00ed; ka\u017edoro\u010dn\u011b (DM2 je kardiovaskul\u00e1rn\u00edm rizikov\u00fdm faktorem)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Je to stejn\u00e9 jako n\u00e1kup Glycomet SR a Glycomet-GP zvl\u00e1\u0161\u0165?<\/h3>\n<p>P\u0159esn\u011b stejn\u00e9 produkty \u2014 Glycomet SR 1000 mg a Glycomet-GP 500\/2 mg od USV, dod\u00e1van\u00e9 spole\u010dn\u011b. Cena balen\u00ed je ni\u017e\u0161\u00ed ne\u017e n\u00e1kup ka\u017ed\u00e9ho produktu zvl\u00e1\u0161\u0165.<\/p>\n<h3 class=\"wp-block-heading\">Kdy bych m\u011bl p\u0159idat slo\u017eku Glycomet-GP?<\/h3>\n<p>Po 12 t\u00fddnech p\u0159i maxim\u00e1ln\u00ed tolerovan\u00e9 d\u00e1vce metforminu, pokud HbA1c z\u016fst\u00e1v\u00e1 nad va\u0161\u00edm individu\u00e1ln\u00edm c\u00edlem (obvykle &gt; 7,0 %). Pokud jste dos\u00e1hli c\u00edlov\u00e9 hodnoty HbA1c pouze s metforminem, ponechte Glycomet-GP v z\u00e1loze \u2014 mnoho pacient\u016f l\u00e9ta dob\u0159e funguje na monoterapii metforminem.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d tyto dva a ne inhibitor SGLT-2 nebo GLP-1?<\/h3>\n<p>Inhibitory SGLT-2 (empagliflozin, dapagliflozin) a agonist\u00e9 GLP-1 (semaglutid, liraglutid) jsou klinicky nad\u0159azen\u00e9 u pacient\u016f se zaveden\u00fdm kardiovaskul\u00e1rn\u00edm onemocn\u011bn\u00edm, srde\u010dn\u00edm selh\u00e1n\u00edm nebo chronick\u00fdm onemocn\u011bn\u00edm ledvin \u2014 sni\u017euj\u00ed v\u00fdznamn\u00e9 kardiovaskul\u00e1rn\u00ed p\u0159\u00edhody nez\u00e1visle na sn\u00ed\u017een\u00ed gluk\u00f3zy. U pacient\u016f bez t\u011bchto p\u0159esv\u011bd\u010div\u00fdch indikac\u00ed z\u016fst\u00e1v\u00e1 metformin + sulfonylurea rozumn\u00fdm, dostupn\u00fdm a \u010dasem ov\u011b\u0159en\u00fdm krokem. Pro pacienty, kte\u0159\u00ed spl\u0148uj\u00ed tyto indikace, nab\u00edz\u00edme samostatn\u011b inhibitory SGLT-2 (Forxiga, Jardiance, Invokana) a GLP-1 (Ozempic, Mounjaro).<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsobuje metformin gastrointestin\u00e1ln\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky?<\/h3>\n<p>Ano \u2014 pr\u016fjem, nevolnost a b\u0159i\u0161n\u00ed diskomfort postihuj\u00ed 20\u201330 % nov\u00fdch u\u017eivatel\u016f. SR formulace v tomto balen\u00ed je speci\u00e1ln\u011b vybr\u00e1na, proto\u017ee sni\u017euje gastrointestin\u00e1ln\u00ed z\u00e1t\u011b\u017e na polovinu ve srovn\u00e1n\u00ed s okam\u017eit\u011b uvol\u0148ovan\u00fdm metforminem. Pokud ne\u017e\u00e1douc\u00ed \u00fa\u010dinky p\u0159etrv\u00e1vaj\u00ed, zpomalte titraci (z\u016fsta\u0148te na 500 mg\/den po dobu 2 t\u00fddn\u016f, pot\u00e9 500 mg dvakr\u00e1t denn\u011b po dobu 2 t\u00fddn\u016f), v\u017edy u\u017e\u00edvejte s j\u00eddlem a zva\u017ete rozd\u011blen\u00ed d\u00e1vky.<\/p>\n<h3 class=\"wp-block-heading\">P\u0159iberu na v\u00e1ze?<\/h3>\n<p>Metformin je neutr\u00e1ln\u00ed k hmotnosti nebo m\u00edrn\u011b sni\u017euje hmotnost. Glimepirid zp\u016fsobuje m\u00edrn\u00fd n\u00e1r\u016fst hmotnosti o 1\u20133 kg za 6\u201312 m\u011bs\u00edc\u016f v pr\u016fm\u011bru (z\u00e1visl\u00fd na inzul\u00ednu a d\u00e1vce). Pro pacienty, kte\u0159\u00ed up\u0159ednost\u0148uj\u00ed hubnut\u00ed, je inhibitor SGLT-2 nebo GLP-1 lep\u0161\u00ed volbou jako druh\u00e1 linie.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017eu p\u00edt alkohol?<\/h3>\n<p>Omezte na 1\u20132 standardn\u00ed n\u00e1poje p\u0159i jedn\u00e9 p\u0159\u00edle\u017eitosti, s j\u00eddlem. Nadm\u011brn\u00e9 nebo n\u00e1razov\u00e9 pit\u00ed na metforminu zvy\u0161uje (vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9) riziko lakt\u00e1tov\u00e9 acid\u00f3zy. Nadm\u011brn\u00e9 pit\u00ed na glimepiridu zvy\u0161uje riziko t\u011b\u017ek\u00e9 hypoglyk\u00e9mie. Vyhn\u011bte se pit\u00ed nala\u010dno.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e onemocn\u00edm nebo p\u0159estanu j\u00edst na den?<\/h3>\n<p>Pokra\u010dujte v u\u017e\u00edv\u00e1n\u00ed obou l\u00e9k\u016f b\u011bhem akutn\u00edho onemocn\u011bn\u00ed se zvracen\u00edm, siln\u00fdm pr\u016fjmem nebo v\u00fdrazn\u011b sn\u00ed\u017een\u00fdm p\u0159\u00edjmem potravy \u2013 dodr\u017eujte \u201cpravidla pro nemocn\u00e9 dny\u201d. Obnovte u\u017e\u00edv\u00e1n\u00ed, a\u017e budete norm\u00e1ln\u011b j\u00edst a dob\u0159e hydratov\u00e1ni. T\u011b\u017ek\u00e1 hypoglyk\u00e9mie zp\u016fsoben\u00e1 glimepiridem b\u011bhem p\u016fstu p\u0159i nemoci je re\u00e1ln\u00e9 riziko.<\/p>\n<h3 class=\"wp-block-heading\">Jak pozn\u00e1m, \u017ee je moje hladina cukru v krvi p\u0159\u00edli\u0161 n\u00edzk\u00e1?<\/h3>\n<p>P\u0159\u00edznaky hypoglyk\u00e9mie: pocen\u00ed, t\u0159es, hlad, bu\u0161en\u00ed srdce, z\u00e1vrat\u011b, zmatenost, zt\u00ed\u017een\u00e1 \u0159e\u010d, zm\u011bny vid\u011bn\u00ed. O\u0161et\u0159ete 15 g rychle p\u016fsob\u00edc\u00edch sacharid\u016f (4\u20135 gluk\u00f3zov\u00fdch tablet, p\u016fl sklenice d\u017eusu, 3 kostky cukru), zkontrolujte hladinu gluk\u00f3zy za 15 minut, opakujte, pokud je &lt; 4 mmol\/l. Nikdy ne\u0159i\u010fte p\u0159i hypoglyk\u00e9mii. P\u0159i u\u017e\u00edv\u00e1n\u00ed glimepiridu v\u017edy noste u sebe gluk\u00f3zov\u00e9 tablety.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017eu platit kryptom\u011bnou?<\/h3>\n<p>Ano \u2014 Bitcoin, Ethereum, USDT a dal\u0161\u00ed hlavn\u00ed kryptom\u011bny p\u0159es Plisio s automatickou 10% slevou p\u0159i placen\u00ed. Viz <a href=\"https:\/\/medsbase.com\/cs\/crypto-payment-guide\/\">Pr\u016fvodce kryptoplatbami<\/a>.<\/p>\n<h3 class=\"wp-block-heading\">Jak je bal\u00ed\u010dek zas\u00edl\u00e1n?<\/h3>\n<p>Diskr\u00e9tn\u00ed obal bez n\u00e1zv\u016f l\u00e9k\u016f na vn\u011bj\u0161\u00ed stran\u011b. Doru\u010den\u00ed po cel\u00e9m sv\u011bt\u011b. <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> pokr\u00fdv\u00e1 bezplatn\u00e9 p\u0159eposl\u00e1n\u00ed, pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f.<\/p>\n<p><!-- mb-bundle-quantities-v1 --><\/p>\n<h2 class=\"wp-block-heading\" id=\"whats-in-each-tier\">Co z\u00edsk\u00e1te v ka\u017ed\u00e9m bal\u00ed\u010dku<\/h2>\n<p>Standardn\u00ed d\u00e1vkov\u00e1n\u00ed obou tablet je jednou denn\u011b. Glycomet-GP obsahuje kombinaci glimepiridu a metforminu 500 mg; Glycomet SR 1000 p\u0159id\u00e1v\u00e1 metformin s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm, aby celkov\u00e1 denn\u00ed d\u00e1vka metforminu byla \u22481500 mg, co\u017e je nejb\u011b\u017en\u011bj\u0161\u00ed po\u010d\u00e1te\u010dn\u00ed re\u017eim pro nov\u011b diagnostikovan\u00fd diabetes 2. typu, kter\u00fd nereagoval na monoterapii metforminem.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0 18px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px 12px;border:1px solid #ddd;text-align:left;\">\u00darove\u0148<\/th>\n<th style=\"padding:10px 12px;border:1px solid #ddd;text-align:left;\">Obsah<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px 12px;border:1px solid #ddd;vertical-align:top;white-space:nowrap;font-weight:600;\">1 m\u011bs\u00edc<\/td>\n<td style=\"padding:10px 12px;border:1px solid #ddd;\">\n<ul style=\"margin:6px 0 0 18px;padding:0;\">\n<li>Glycomet SR 1000 (metformin XR 1000 mg) \u2014 30 tablet<\/li>\n<li>Glycomet-GP 1 (glimepirid 1 mg + metformin 500 mg) \u2014 30 tablet<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 12px;border:1px solid #ddd;vertical-align:top;white-space:nowrap;font-weight:600;\">3 m\u011bs\u00edce<\/td>\n<td style=\"padding:10px 12px;border:1px solid #ddd;\">\n<ul style=\"margin:6px 0 0 18px;padding:0;\">\n<li>Glycomet SR 1000 (metformin XR 1000 mg) \u2014 90 tablet<\/li>\n<li>Glycomet-GP 1 (glimepirid 1 mg + metformin 500 mg) \u2014 90 tablet<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 12px;border:1px solid #ddd;vertical-align:top;white-space:nowrap;font-weight:600;\">6 m\u011bs\u00edc\u016f<\/td>\n<td style=\"padding:10px 12px;border:1px solid #ddd;\">\n<ul style=\"margin:6px 0 0 18px;padding:0;\">\n<li>Glycomet SR 1000 (metformin XR 1000 mg) \u2014 180 tablet<\/li>\n<li>Glycomet-GP 1 (glimepirid 1 mg + metformin 500 mg) \u2014 180 tablet<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/mb-bundle-quantities-v1 --><\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2 class=\"wp-block-heading\">Tak\u00e9 v na\u0161\u00ed nab\u00eddce l\u00e9k\u016f na diabetes<\/h2>\n<ul>\n<li><strong>Samotn\u00fd metformin:<\/strong> <a href=\"https:\/\/medsbase.com\/cs\/glycomet-sr\/\">Glycomet SR<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/biciphage-1000-sr\/\">Biciphage 1000 SR<\/a><\/li>\n<li><strong>Alternativy kombinace metforminu a glimepiridu:<\/strong> <a href=\"https:\/\/medsbase.com\/cs\/glycomet-gp\/\">Glycomet-GP<\/a><\/li>\n<li><strong>Metformin + glipizid v kombinaci:<\/strong> <a href=\"https:\/\/medsbase.com\/cs\/glynase-mf\/\">Glynase-MF<\/a><\/li>\n<li><strong>SGLT-2 inhibitory (kardio-ren\u00e1ln\u00ed ochrana):<\/strong> <a href=\"https:\/\/medsbase.com\/cs\/invokana-canagliflozin\/\">Invokana<\/a><\/li>\n<li><strong>DPP-4 inhibitory:<\/strong> viz kompletn\u00ed <a href=\"https:\/\/medsbase.com\/cs\/diabetes-medication\/\">Kategorie l\u00e9k\u016f na diabetes<\/a><\/li>\n<li><strong>GLP-1 agonist\u00e9 (alternativy k Ozempicu):<\/strong> viz na\u0161e <a href=\"https:\/\/medsbase.com\/cs\/how-to-get-ozempic-for-weight-loss\/\">Nejlep\u0161\u00ed alternativy Ozempicu 2026<\/a> p\u0159\u00edru\u010dka<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">D\u016fle\u017eit\u00e9 bezpe\u010dnostn\u00ed informace<\/h2>\n<p>Diabetes Starter Pack obsahuje l\u00e9ky ur\u010den\u00e9 k u\u017e\u00edv\u00e1n\u00ed pod l\u00e9ka\u0159sk\u00fdm dohledem. L\u00e9\u010dba diabetu 2. typu vy\u017eaduje pravideln\u00e9 monitorov\u00e1n\u00ed HbA1c, funkce ledvin a hodnocen\u00ed kardiovaskul\u00e1rn\u00edho rizika. Neu\u017e\u00edvejte metformin p\u0159i eGFR &lt; 30 ml\/min, t\u011b\u017ek\u00e9 jatern\u00ed nedostate\u010dnosti nebo p\u0159i akutn\u00ed dehydrataci\/onemocn\u011bn\u00ed. P\u0159eru\u0161te metformin 48 hodin p\u0159ed a po vy\u0161et\u0159en\u00ed s IV kontrastn\u00ed l\u00e1tkou. Glimepirid m\u016f\u017ee zp\u016fsobit hypoglyk\u00e9mii \u2014 v\u017edy m\u011bjte u sebe gluk\u00f3zov\u00e9 tablety a p\u0159i \u010dast\u00fdch hypoglyk\u00e9mi\u00edch informujte l\u00e9ka\u0159e. Neu\u017e\u00edvejte tyto l\u00e9ky p\u0159i diabetu 1. typu, v t\u011bhotenstv\u00ed bez odborn\u00e9ho dohledu nebo p\u0159i zn\u00e1m\u00e9 p\u0159ecitliv\u011blosti na sulfonylmo\u010doviny. Okam\u017eit\u011b p\u0159eru\u0161te l\u00e9\u010dbu a vyhledejte l\u00e9ka\u0159skou pomoc p\u0159i t\u011b\u017ek\u00e9 hypoglyk\u00e9mii neovlivniteln\u00e9 peror\u00e1ln\u00edmi sacharidy, siln\u00e9 bolesti b\u0159icha (lakt\u00e1tov\u00e1 acid\u00f3za), \u017eloutence nebo zn\u00e1mk\u00e1ch t\u011b\u017ek\u00e9 p\u0159ecitliv\u011blosti. Tato str\u00e1nka slou\u017e\u00ed pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nenahrazuje konzultaci s kvalifikovan\u00fdm l\u00e9ka\u0159em.<\/p>","protected":false},"excerpt":{"rendered":"<p>Startovac\u00ed bal\u00ed\u010dek pro diabetes \u2014 Glycomet SR 1000 mg (metformin) + Glycomet-GP 500\/2 mg (metformin + glimepirid) v bal\u00ed\u010dku. Prvn\u00ed volba + postupn\u00fd re\u017eim pro nov\u011b diagnostikovan\u00fd diabetes 2. typu podle doporu\u010den\u00ed ADA\/EASD\/NICE. Pouze pod odborn\u00fdm dohledem.<\/p>","protected":false},"featured_media":70080,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3223,3231],"product_tag":[5833,5918,3251,5919,3254,5908,3255,5920,5834,5921,5922,5923],"class_list":{"0":"post-70072","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-chronic-conditions","7":"product_cat-diabetes-medication","8":"product_tag-bundle","9":"product_tag-diabetes-medication","10":"product_tag-glimepiride","11":"product_tag-glycomet","12":"product_tag-glycomet-gp","13":"product_tag-medsbase-pack","14":"product_tag-metformin","15":"product_tag-newly-diagnosed","16":"product_tag-stack","17":"product_tag-sulfonylurea","18":"product_tag-t2dm","19":"product_tag-type-2-diabetes","21":"first","22":"instock","23":"shipping-taxable","24":"purchasable","25":"product-type-variable","26":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/70072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=70072"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70080"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=70072"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=70072"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=70072"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=70072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}